Clinical trials · San Francisco, CA
Recessive Dystrophic Epidermolysis Bullosa clinical trials in San Francisco
We’re tracking 4 recruiting recessive dystrophic epidermolysis bullosa studies with a site in or near San Francisco — including Phase 1/Phase 2 studies, each written for real people, not researchers.
Recruiting studies near San Francisco
- NCT06834035RecruitingPhase 1/Phase 2
IV IgG for collagen VII antibodies in dystrophic epidermolysis bullosa
This trial tests if intravenous immunoglobulin (IV IgG) can help people with a form of epidermolysis bullosa who have antibodies against collagen VII. It may reduce blistering and improve wound healing.
Redwood City, CaliforniaAges 6 years+ - NCT04917887Recruiting
Gene therapy long-term follow-up for Krystal Biotech patients
This study follows people who previously received a gene therapy from Krystal Biotech to better understand long-term safety and outcomes. If you already had their gene therapy before and you can keep follow-up appointments, you may be able to join.
Redwood City, CaliforniaAges 6 months+ - NCT07700966Recruiting
Long-term safety registry for EB treatment
This study follows patients who have already received a gene therapy treatment called prademagene zamikeracel for a severe skin condition called recessive dystrophic epidermolysis bullosa (RDEB). The goal is to track long-term safety and health outcomes after treatment.
Palo Alto, CaliforniaAges Any age - NCT01019148Recruiting
Study of people with recessive dystrophic epidermolysis bullosa
This study looks at the medical features and needs of people who have recessive dystrophic epidermolysis bullosa (RDEB). It may help doctors better understand the condition and plan better care.
Stanford, CaliforniaAges Any age
Hear when a new Recessive Dystrophic Epidermolysis Bullosa trial opens near San Francisco, CA
We’ll email you when one opens near San Francisco, CA — at most once a week, no account needed, unsubscribe anytime.
Recessive Dystrophic Epidermolysis Bullosa trials in other cities
Where these studies are running near San Francisco
Institutions with a site for the recruiting recessive dystrophic epidermolysis bullosa studies listed above.
- Stanford University · 3 studies
- Lucile Packard Children's Hospital at Stanford
What taking part in a recessive dystrophic epidermolysis bullosa study involves
A screening visit first
Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.
Care at a nearby site
Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.
You stay in control
Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.
The team decides eligibility
Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.
Looking wider? See all recruiting recessive dystrophic epidermolysis bullosa studies in California.
Common questions
- Are there recessive dystrophic epidermolysis bullosa clinical trials near San Francisco?
- Yes. We're currently tracking 4 recruiting recessive dystrophic epidermolysis bullosa studies with a site near San Francisco, each rewritten in plain language so you can see what it's testing and who it's for.
- How do I find out if I qualify for a recessive dystrophic epidermolysis bullosa study near San Francisco?
- Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Do I have to live in San Francisco to take part?
- Not necessarily. These studies have a site near San Francisco, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
- Does it cost anything to join a recessive dystrophic epidermolysis bullosa trial?
- Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.
Not the right time?
New recessive dystrophic epidermolysis bullosa studies open near San Francisco regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.